{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:32:33Z","timestamp":1785461553838,"version":"3.56.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200229"],"award-info":[{"award-number":["82200229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4930"],"award-info":[{"award-number":["2020JJ4930"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12035-025-04961-y","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T02:24:40Z","timestamp":1745547880000},"page":"11297-11316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association Between T2DM, TyG Index, Multiple Sclerosis, and Rheumatoid Arthritis: Insights into Potential Mechanisms"],"prefix":"10.1007","volume":"62","author":[{"given":"Yi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runxin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"4961_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1871530322666220908154253","volume":"23","author":"M Garc\u00eda-Carrasco","year":"2023","unstructured":"Garc\u00eda-Carrasco M et al (2023) Insulin resistance and diabetes mellitus in patients with systemic lupus erythematosus. Endocr Metab Immune Disord Drug Targets 23:503\u2013514. https:\/\/doi.org\/10.2174\/1871530322666220908154253","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"Suppl 2","key":"4961_CR2","doi-asserted-by":"publisher","first-page":"S1013","DOI":"10.1016\/j.dsx.2017.07.032","volume":"11","author":"R Rajput","year":"2017","unstructured":"Rajput R, Dangi A, Singh H (2017) Prevalence of glucose intolerance in rheumatoid arthritis patients at a tertiary care centre in Haryana. Diabetes Metab Syndr 11(Suppl 2):S1013-s1016. https:\/\/doi.org\/10.1016\/j.dsx.2017.07.032","journal-title":"Diabetes Metab Syndr"},{"key":"4961_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12902-024-01675-5","volume":"24","author":"Z Bagheri-Hosseinabadi","year":"2024","unstructured":"Bagheri-Hosseinabadi Z, Moadab F, Abbasifard M (2024) Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients. BMC Endocr Disord 24:140. https:\/\/doi.org\/10.1186\/s12902-024-01675-5","journal-title":"BMC Endocr Disord"},{"key":"4961_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.je.2016.06.006","volume":"27","author":"WH Hou","year":"2017","unstructured":"Hou WH, Li CY, Chang HH, Sun Y, Tsai CC (2017) A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus. J Epidemiol 27:235\u2013241. https:\/\/doi.org\/10.1016\/j.je.2016.06.006","journal-title":"J Epidemiol"},{"key":"4961_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.autrev.2018.02.007","volume":"17","author":"K Van Raemdonck","year":"2018","unstructured":"Van Raemdonck K, Umar S, Szekanecz Z, Zomorrodi RK, Shahrara S (2018) Impact of obesity on autoimmune arthritis and its cardiovascular complications. Autoimmun Rev 17:821\u2013835. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.007","journal-title":"Autoimmun Rev"},{"key":"4961_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12944-022-01735-6","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z et al (2022) Predictive value of the TyG index and rheumatoid factor for cardiovascular disease risk in a rheumatoid arthritis population: data from a survey of 418 patients. Lipids Health Dis 21:122. https:\/\/doi.org\/10.1186\/s12944-022-01735-6","journal-title":"Lipids Health Dis"},{"key":"4961_CR7","doi-asserted-by":"publisher","first-page":"e101528","DOI":"10.1371\/journal.pone.0101528","volume":"9","author":"MC Lu","year":"2014","unstructured":"Lu MC, Yan ST, Yin WY, Koo M, Lai NS (2014) Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study. PLoS One 9:e101528. https:\/\/doi.org\/10.1371\/journal.pone.0101528","journal-title":"PLoS One"},{"key":"4961_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2012-202481","volume":"73","author":"M Lahiri","year":"2014","unstructured":"Lahiri M et al (2014) Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European prospective investigation of Cancer-Norfolk and the Norfolk arthritis register\u2013the EPIC-2-NOAR study). Ann Rheum Dis 73:219\u2013226. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202481","journal-title":"Ann Rheum Dis"},{"key":"4961_CR9","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1093\/rheumatology\/keab148","volume":"60","author":"DT Zemedikun","year":"2021","unstructured":"Zemedikun DT et al (2021) Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study. Rheumatol (Oxford) 60:5567\u20135575. https:\/\/doi.org\/10.1093\/rheumatology\/keab148","journal-title":"Rheumatol (Oxford)"},{"key":"4961_CR10","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson SC, Butterworth AS, Burgess S (2023) Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J 44:4913\u20134924. https:\/\/doi.org\/10.1093\/eurheartj\/ehad736","journal-title":"Eur Heart J"},{"key":"4961_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG (2015) Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 30:543\u2013552. https:\/\/doi.org\/10.1007\/s10654-015-0011-z","journal-title":"Eur J Epidemiol"},{"key":"4961_CR12","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. Jama 326:1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"Jama"},{"key":"4961_CR13","doi-asserted-by":"publisher","first-page":"583473","DOI":"10.3389\/fcvm.2020.583473","volume":"7","author":"S Si","year":"2020","unstructured":"Si S et al (2020) Causal effect of the triglyceride-glucose index and the joint exposure of higher glucose and triglyceride with extensive cardio-cerebrovascular metabolic outcomes in the UK Biobank: a Mendelian randomization study. Front Cardiovasc Med 7:583473. https:\/\/doi.org\/10.3389\/fcvm.2020.583473","journal-title":"Front Cardiovasc Med"},{"key":"4961_CR14","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41467-018-04951-w","volume":"9","author":"A Xue","year":"2018","unstructured":"Xue A et al (2018) Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun 9:2941. https:\/\/doi.org\/10.1038\/s41467-018-04951-w","journal-title":"Nat Commun"},{"key":"4961_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","volume":"21","author":"X Li","year":"2022","unstructured":"Li X et al (2022) Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a Mendelian randomization analysis. Cardiovasc Diabetol 21:229. https:\/\/doi.org\/10.1186\/s12933-022-01658-7","journal-title":"Cardiovasc Diabetol"},{"key":"4961_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.ajkd.2021.04.018","volume":"79","author":"S Yuan","year":"2022","unstructured":"Yuan S, Larsson SC (2022) Coffee and caffeine consumption and risk of kidney stones: a Mendelian randomization study. Am J Kidney Dis 79:9-14.e11. https:\/\/doi.org\/10.1053\/j.ajkd.2021.04.018","journal-title":"Am J Kidney Dis"},{"key":"4961_CR17","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR et al (2016) PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32:3207\u20133209. https:\/\/doi.org\/10.1093\/bioinformatics\/btw373","journal-title":"Bioinformatics"},{"key":"4961_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/s0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N et al (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 400:733\u2013743. https:\/\/doi.org\/10.1016\/s0140-6736(22)01349-6","journal-title":"Lancet"},{"key":"4961_CR19","doi-asserted-by":"publisher","unstructured":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol 12, e2-e11 (2024). https:\/\/doi.org\/10.1016\/s2213-8587(23)00287-5","DOI":"10.1016\/s2213-8587(23)00287-5"},{"key":"4961_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52:1036\u20131045. https:\/\/doi.org\/10.1038\/s41588-020-0684-4","journal-title":"Nat Genet"},{"key":"4961_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"4961_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44:512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"key":"4961_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3758\/s13428-011-0076-x","volume":"43","author":"D Tofighi","year":"2011","unstructured":"Tofighi D, MacKinnon DP (2011) RMediation: an R package for mediation analysis confidence intervals. Behav Res Methods 43:692\u2013700. https:\/\/doi.org\/10.3758\/s13428-011-0076-x","journal-title":"Behav Res Methods"},{"key":"4961_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3758\/bf03206553","volume":"36","author":"KJ Preacher","year":"2004","unstructured":"Preacher KJ, Hayes AF (2004) SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 36:717\u2013731. https:\/\/doi.org\/10.3758\/bf03206553","journal-title":"Behav Res Methods Instrum Comput"},{"key":"4961_CR25","doi-asserted-by":"publisher","unstructured":"Hemani G et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7. https:\/\/doi.org\/10.7554\/eLife.34408","DOI":"10.7554\/eLife.34408"},{"key":"4961_CR26","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S (2017) Mendelian Randomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 46:1734\u20131739. https:\/\/doi.org\/10.1093\/ije\/dyx034","journal-title":"Int J Epidemiol"},{"key":"4961_CR27","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10:e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"key":"4961_CR28","doi-asserted-by":"publisher","first-page":"e1009440","DOI":"10.1371\/journal.pgen.1009440","volume":"17","author":"C Wallace","year":"2021","unstructured":"Wallace C (2021) A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet 17:e1009440. https:\/\/doi.org\/10.1371\/journal.pgen.1009440","journal-title":"PLoS Genet"},{"key":"4961_CR29","doi-asserted-by":"publisher","first-page":"104494","DOI":"10.1016\/j.ebiom.2023.104494","volume":"89","author":"J Chen","year":"2023","unstructured":"Chen J et al (2023) Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses. EBioMedicine 89:104494. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104494","journal-title":"EBioMedicine"},{"key":"4961_CR30","doi-asserted-by":"publisher","unstructured":"Schafflick D et al (2020) Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nature Communications 11. https:\/\/doi.org\/10.1038\/s41467-019-14118-w","DOI":"10.1038\/s41467-019-14118-w"},{"key":"4961_CR31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"4961_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42:293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y","journal-title":"Nat Biotechnol"},{"key":"4961_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-023-01971-9","volume":"22","author":"Z Yang","year":"2023","unstructured":"Yang Z, Gong H, Kan F, Ji N (2023) Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database. Cardiovasc Diabetol 22:232. https:\/\/doi.org\/10.1186\/s12933-023-01971-9","journal-title":"Cardiovasc Diabetol"},{"key":"4961_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J et al (2022) TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol 21:123. https:\/\/doi.org\/10.1186\/s12933-022-01548-y","journal-title":"Cardiovasc Diabetol"},{"key":"4961_CR35","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/celldisc.2017.20","volume":"3","author":"G Cao","year":"2017","unstructured":"Cao G et al (2017) Long-term consumption of caffeine-free high sucrose cola beverages aggravates the pathogenesis of EAE in mice. Cell Discov 3:17020. https:\/\/doi.org\/10.1038\/celldisc.2017.20","journal-title":"Cell Discov"},{"key":"4961_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.immuni.2019.08.001","volume":"51","author":"D Zhang","year":"2019","unstructured":"Zhang D et al (2019) High glucose intake exacerbates autoimmunity through reactive-oxygen-species-mediated TGF-\u03b2 cytokine activation. Immunity 51:671-681.e675. https:\/\/doi.org\/10.1016\/j.immuni.2019.08.001","journal-title":"Immunity"},{"key":"4961_CR37","doi-asserted-by":"publisher","first-page":"148648","DOI":"10.1016\/j.brainres.2023.148648","volume":"1822","author":"EAB Gilbert","year":"2024","unstructured":"Gilbert EAB et al (2024) Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis. Brain Res 1822:148648. https:\/\/doi.org\/10.1016\/j.brainres.2023.148648","journal-title":"Brain Res"},{"key":"4961_CR38","doi-asserted-by":"publisher","unstructured":"Giannopapas V et al (2023) The prevalence of diabetes mellitus type II (DMII) in the multiple sclerosis population: a systematic review and meta-analysis. J Clin Med 12. https:\/\/doi.org\/10.3390\/jcm12154948","DOI":"10.3390\/jcm12154948"},{"key":"4961_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/rheumatology\/key038","volume":"58","author":"V De Vita","year":"2019","unstructured":"De Vita V, Melnik BC (2019) Activation of mechanistic target of rapamycin complex 1: the common link between rheumatoid arthritis and diabetes mellitus. Rheumatol (Oxford) 58:377\u2013379. https:\/\/doi.org\/10.1093\/rheumatology\/key038","journal-title":"Rheumatol (Oxford)"},{"key":"4961_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s10038-020-00837-2","volume":"66","author":"J Inamo","year":"2021","unstructured":"Inamo J, Kochi Y, Takeuchi T (2021) Is type 2 diabetes mellitus an inverse risk factor for the development of rheumatoid arthritis? J Hum Genet 66:219\u2013223. https:\/\/doi.org\/10.1038\/s10038-020-00837-2","journal-title":"J Hum Genet"},{"key":"4961_CR41","doi-asserted-by":"publisher","first-page":"e13804","DOI":"10.1111\/ijcp.13804","volume":"75","author":"MS Hsieh","year":"2021","unstructured":"Hsieh MS, Hung PS, Hsieh VC, Liao SH, How CK (2021) Association between thiazolidinedione use and rheumatoid arthritis risk in patients with type II diabetes, a population-based, case-control study. Int J Clin Pract 75:e13804. https:\/\/doi.org\/10.1111\/ijcp.13804","journal-title":"Int J Clin Pract"},{"key":"4961_CR42","doi-asserted-by":"publisher","first-page":"934184","DOI":"10.3389\/fmed.2022.934184","volume":"9","author":"YJ Su","year":"2022","unstructured":"Su YJ, Huang JY, Chu CQ, Wei JC (2022) Sulfonylureas or biguanides is associated with a lower risk of rheumatoid arthritis in patients with diabetes: a nationwide cohort study. Front Med (Lausanne) 9:934184. https:\/\/doi.org\/10.3389\/fmed.2022.934184","journal-title":"Front Med (Lausanne)"},{"key":"4961_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.msard.2018.08.014","volume":"25","author":"A Ruiz-Arg\u00fcelles","year":"2018","unstructured":"Ruiz-Arg\u00fcelles A, M\u00e9ndez-Huerta MA, Lozano CD, Ruiz-Arg\u00fcelles GJ (2018) Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease. Mult Scler Relat Disord 25:316\u2013321. https:\/\/doi.org\/10.1016\/j.msard.2018.08.014","journal-title":"Mult Scler Relat Disord"},{"key":"4961_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nut.2013.08.001","volume":"30","author":"SR Oliveira","year":"2014","unstructured":"Oliveira SR et al (2014) Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition 30:268\u2013273. https:\/\/doi.org\/10.1016\/j.nut.2013.08.001","journal-title":"Nutrition"},{"key":"4961_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2015.5050","volume":"73","author":"A Haghikia","year":"2016","unstructured":"Haghikia A, Gold R (2016) Positive effect on multiple sclerosis with treatment of metabolic syndrome. JAMA Neurol 73:499\u2013501. https:\/\/doi.org\/10.1001\/jamaneurol.2015.5050","journal-title":"JAMA Neurol"},{"key":"4961_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I et al (2018) Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis. Cell 175:85-100.e123. https:\/\/doi.org\/10.1016\/j.cell.2018.08.011","journal-title":"Cell"},{"key":"4961_CR47","doi-asserted-by":"publisher","first-page":"e0182927","DOI":"10.1371\/journal.pone.0182927","volume":"12","author":"RA Moura","year":"2017","unstructured":"Moura RA et al (2017) B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. PLoS One 12:e0182927. https:\/\/doi.org\/10.1371\/journal.pone.0182927","journal-title":"PLoS One"},{"key":"4961_CR48","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.4049\/jimmunol.1801236","volume":"203","author":"J Fraussen","year":"2019","unstructured":"Fraussen J et al (2019) Phenotypic and Ig repertoire analyses indicate a common origin of IgD(-)CD27(-) double negative B cells in healthy individuals and multiple sclerosis patients. J Immunol 203:1650\u20131664. https:\/\/doi.org\/10.4049\/jimmunol.1801236","journal-title":"J Immunol"},{"key":"4961_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0092-8674(88)90533-8","volume":"52","author":"JJ Sussman","year":"1988","unstructured":"Sussman JJ et al (1988) Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell 52:85\u201395. https:\/\/doi.org\/10.1016\/0092-8674(88)90533-8","journal-title":"Cell"},{"key":"4961_CR50","doi-asserted-by":"publisher","first-page":"103013","DOI":"10.1016\/j.msard.2021.103013","volume":"52","author":"VO Boldrini","year":"2021","unstructured":"Boldrini VO et al (2021) Cytotoxic profile of CD3+CD20+ T cells in progressive multiple sclerosis. Mult Scler Relat Disord 52:103013. https:\/\/doi.org\/10.1016\/j.msard.2021.103013","journal-title":"Mult Scler Relat Disord"},{"key":"4961_CR51","doi-asserted-by":"publisher","first-page":"e0134089","DOI":"10.1371\/journal.pone.0134089","volume":"10","author":"N Jovicic","year":"2015","unstructured":"Jovicic N et al (2015) Differential immunometabolic phenotype in Th1 and Th2 dominant mouse strains in response to high-fat feeding. PLoS One 10:e0134089. https:\/\/doi.org\/10.1371\/journal.pone.0134089","journal-title":"PLoS One"},{"key":"4961_CR52","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm.2001","volume":"15","author":"S Winer","year":"2009","unstructured":"Winer S et al (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15:921\u2013929. https:\/\/doi.org\/10.1038\/nm.2001","journal-title":"Nat Med"},{"key":"4961_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41419-023-05937-3","volume":"14","author":"J Cao","year":"2023","unstructured":"Cao J et al (2023) Effects of altered glycolysis levels on CD8(+) T cell activation and function. Cell Death Dis 14:407. https:\/\/doi.org\/10.1038\/s41419-023-05937-3","journal-title":"Cell Death Dis"},{"key":"4961_CR54","doi-asserted-by":"publisher","first-page":"730342","DOI":"10.3389\/fimmu.2021.730342","volume":"12","author":"G Tilly","year":"2021","unstructured":"Tilly G et al (2021) Teriflunomide treatment of multiple sclerosis selectively modulates CD8 memory T cells. Front Immunol 12:730342. https:\/\/doi.org\/10.3389\/fimmu.2021.730342","journal-title":"Front Immunol"},{"key":"4961_CR55","doi-asserted-by":"publisher","first-page":"100518","DOI":"10.1016\/j.lansea.2024.100518","volume":"32","author":"L Rathod","year":"2025","unstructured":"Rathod L et al (2025) Genetic variants and type 2 diabetes in India: a systematic review and meta-analysis of associated polymorphisms in case-control studies. Lancet Reg Health Southeast Asia 32:100518. https:\/\/doi.org\/10.1016\/j.lansea.2024.100518","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"4961_CR56","doi-asserted-by":"publisher","first-page":"20062","DOI":"10.1038\/s41598-024-70674-2","volume":"14","author":"K Yanasegaran","year":"2024","unstructured":"Yanasegaran K et al (2024) Single nucleotide polymorphisms (SNPs) that are associated with obesity and type 2 diabetes among Asians: a systematic review and meta-analysis. Sci Rep 14:20062. https:\/\/doi.org\/10.1038\/s41598-024-70674-2","journal-title":"Sci Rep"},{"key":"4961_CR57","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/13816810.2024.2318611","volume":"45","author":"L Alidoust","year":"2024","unstructured":"Alidoust L, Sharafshah A, Keshavarz P (2024) Haplotype-based association study of TCF7L2 gene variants with the development of diabetic retinopathy in an Iranian population. Ophthalmic Genet 45:226\u2013232. https:\/\/doi.org\/10.1080\/13816810.2024.2318611","journal-title":"Ophthalmic Genet"},{"key":"4961_CR58","doi-asserted-by":"publisher","first-page":"e52709","DOI":"10.7759\/cureus.52709","volume":"16","author":"S Kumar","year":"2024","unstructured":"Kumar S, Prakash P, Kumari R, Kumar N (2024) Genetic association of transcription factor 7-like-2 rs7903146 polymorphism with type 2 diabetes mellitus. Cureus 16:e52709. https:\/\/doi.org\/10.7759\/cureus.52709","journal-title":"Cureus"},{"key":"4961_CR59","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtumed.2024.04.005","volume":"19","author":"AH Younus","year":"2024","unstructured":"Younus AH, Al-Faisal AHM (2024) Correlation between TCF7L2 gene expression and certain biochemical parameters in type 2 diabetes mellitus. J Taibah Univ Med Sci 19:575\u2013584. https:\/\/doi.org\/10.1016\/j.jtumed.2024.04.005","journal-title":"J Taibah Univ Med Sci"},{"key":"4961_CR60","doi-asserted-by":"publisher","first-page":"17122","DOI":"10.1038\/s41598-023-43560-6","volume":"13","author":"NE Ngwa","year":"2023","unstructured":"Ngwa NE, Matshazi DM, Davison GM, Kengne AP, Matsha TE (2023) Association between the MTNR1B, HHEX, SLC30A8, and TCF7L2 single nucleotide polymorphisms and cardiometabolic risk profile in a mixed ancestry South African population. Sci Rep 13:17122. https:\/\/doi.org\/10.1038\/s41598-023-43560-6","journal-title":"Sci Rep"},{"key":"4961_CR61","doi-asserted-by":"publisher","first-page":"e72822","DOI":"10.1371\/journal.pone.0072822","volume":"8","author":"A L\u00fcrbke","year":"2013","unstructured":"L\u00fcrbke A et al (2013) Limited TCF7L2 expression in MS lesions. PLoS One 8:e72822. https:\/\/doi.org\/10.1371\/journal.pone.0072822","journal-title":"PLoS One"},{"key":"4961_CR62","doi-asserted-by":"publisher","unstructured":"Yadav R, Patel B (2024) Insights on effects of Wnt pathway modulation on insulin signaling and glucose homeostasis for the treatment of type 2 diabetes mellitus: Wnt activation or Wnt inhibition? International Journal of Biological Macromolecules 261. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129634","DOI":"10.1016\/j.ijbiomac.2024.129634"},{"key":"4961_CR63","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10571-017-0550-9","volume":"38","author":"A Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e A, Vall\u00e9e JN, Guillevin R, Lecarpentier Y (2018) Interactions between the canonical WNT\/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis. Cell Mol Neurobiol 38:783\u2013795. https:\/\/doi.org\/10.1007\/s10571-017-0550-9","journal-title":"Cell Mol Neurobiol"},{"key":"4961_CR64","doi-asserted-by":"publisher","first-page":"109847","DOI":"10.1016\/j.clim.2023.109847","volume":"257","author":"C Skarlis","year":"2023","unstructured":"Skarlis C, Papadopoulos V, Raftopoulou S, Mavragani CP, Evangelopoulos ME (2023) B-cell activating factor gene variants in multiple sclerosis: possible associations with disease susceptibility among females. Clin Immunol 257:109847. https:\/\/doi.org\/10.1016\/j.clim.2023.109847","journal-title":"Clin Immunol"},{"key":"4961_CR65","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJMoa1610528","volume":"376","author":"M Steri","year":"2017","unstructured":"Steri M et al (2017) Overexpression of the cytokine BAFF and autoimmunity risk. N Engl J Med 376:1615\u20131626. https:\/\/doi.org\/10.1056\/NEJMoa1610528","journal-title":"N Engl J Med"},{"key":"4961_CR66","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Breijo B et al (2022) Low serum BAFF concentration is associated with response to TNF inhibitors in seropositive patients with rheumatoid arthritis. J Clin Med 11. https:\/\/doi.org\/10.3390\/jcm11175207","DOI":"10.3390\/jcm11175207"},{"key":"4961_CR67","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/rheumatology\/keac337","volume":"62","author":"N Kintrilis","year":"2023","unstructured":"Kintrilis N et al (2023) Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sj\u00f6gren\u2019s syndrome: the impact of BAFF genetic variations. Rheumatol (Oxford) 62:958\u2013968. https:\/\/doi.org\/10.1093\/rheumatology\/keac337","journal-title":"Rheumatol (Oxford)"},{"key":"4961_CR68","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/acr2.11487","volume":"4","author":"L Abuqayyas","year":"2022","unstructured":"Abuqayyas L et al (2022) Safety and biological activity of rozibafusp alfa, a bispecific inhibitor of inducible costimulator ligand and B cell activating factor, in patients with rheumatoid arthritis: results of a phase 1b, randomized, double-blind, placebo-controlled, multiple ascending dose study. ACR Open Rheumatol 4:903\u2013911. https:\/\/doi.org\/10.1002\/acr2.11487","journal-title":"ACR Open Rheumatol"},{"key":"4961_CR69","doi-asserted-by":"publisher","first-page":"123046","DOI":"10.1016\/j.jns.2024.123046","volume":"461","author":"C Skarlis","year":"2024","unstructured":"Skarlis C, Papadopoulos V, Raftopoulou S, Mavragani CP, Evangelopoulos ME (2024) Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: implications for progressive multifocal leukoencephalopathy risk stratification. J Neurol Sci 461:123046. https:\/\/doi.org\/10.1016\/j.jns.2024.123046","journal-title":"J Neurol Sci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04961-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:06:47Z","timestamp":1755662807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04961-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4961"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04961-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because the data analyzed in the present study are publicly available, no additional ethical approval or written consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}